Our study further substantiates previous findings regarding the positive correlation between FOS expression and overall survival (OS) in breast cancer [50] and specifically highlights an association between increased FOS expression and improved survival outcomes in HER2 breast cancer patients. The gene discussed is ERBB2; the disease is breast carcinoma.